Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2022

  1. Acute intraocular toxicity caused by perfluorocarbon liquids: safety control systems of medical devices

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 260, Núm. 7, pp. 2103-2110

2021

  1. Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery

    Regulatory Toxicology and Pharmacology, Vol. 110

  2. Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases

    Stem Cells International, Vol. 2020

2019

  1. Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis

    British Journal of Ophthalmology, Vol. 103, Núm. 1, pp. 49-54

  2. Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures

    Experimental Eye Research, Vol. 185

2018

  1. Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 256, Núm. 1, pp. 125-134

  2. Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation

    Scientific Reports, Vol. 8, Núm. 1

  3. Retinal toxicity of medical devices used during vitreoretinal surgery: A critical overview

    Ophthalmologica, Vol. 240, Núm. 4, pp. 236-243

2017

  1. Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery

    Retina, Vol. 37, Núm. 6, pp. 1140-1151

2016

  1. Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical t

    World Journal of Stem Cells